Maquet Cardiovascular recalled the Heartstring III Proximal Seal System on August 15, 2025, due to three identified failure modes. These failures include issues with the seal's loading, deployment, and hemostasis. The recall affects 168 units distributed worldwide.
Three failure modes have been identified: failure of the Heartstring Seal to load, failure of the Heartstring Seal to deploy into the aortotomy, and failure of the deployed Heartstring Seal to provide adequate hemostasis.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Maquet Cardiovascular, LLC or your healthcare provider for instructions. Notification method: Letter
The recalled Heartstring III Proximal Seal System includes model HS-3045 and UDI 00607567700307. Other serial numbers affected are 3000365549, 3000428264, 3000447331, 3000460255, 3000390361, 3000420107, and 3000475915. The device was distributed in various countries, including the US, Canada, and several European nations.
The recall addresses high-risk failure modes that can lead to inadequate hemostasis during medical procedures. Such failures can pose significant risks to patients undergoing vascular surgeries.
No specific incidents or injuries have been reported related to this recall. The manufacturer emphasizes immediate cessation of use.
Patients and healthcare providers must stop using the device immediately. Follow the recall instructions provided by the manufacturer. Contact Maquet Cardiovascular or your healthcare provider for further guidance.
For more details, contact Maquet Cardiovascular at their official website or through the recall notification letter.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.